Trials / Completed
CompletedNCT01364207
The Effects of Caffeinated Coffee on Intraocular Pressure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Massachusetts Eye and Ear Infirmary · Academic / Other
- Sex
- All
- Age
- 40 Years – 89 Years
- Healthy volunteers
- Accepted
Summary
High intraocular pressure (IOP) is a known risk factor for developing primary open-angle glaucoma (POAG). There is controversy in the literature regarding the degree to which caffeine influences IOP, with some studies reporting minimal changes in IOP while others report up to 4 mmHg increases. To date there are no double-masked randomized controlled trials that examine acute caffeinated coffee's effects on IOP in patients with or at risk for primary open-angle glaucoma. The investigators aim to better understand the relationship between acute caffeinated coffee (vs decaffeinate coffee) consumption and IOP in a double-masked, crossover randomized controlled clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Caffeinated Coffee | Participants will drink one 8 oz cup in the morning hours. Participants have 15 minutes to drink the coffee but may do so in less time. |
| OTHER | Decaffeinated Coffee | Participants will drink one 8 oz cup in the morning hours. Participants have 15 minutes to drink the coffee but may do so in less time. |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-08-01
- Completion
- 2012-06-01
- First posted
- 2011-06-02
- Last updated
- 2012-10-31
- Results posted
- 2012-10-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01364207. Inclusion in this directory is not an endorsement.